Epilepsy and Seizure Medication
  Novartis Pharma US

 




Novartis Medicare Resource Center

Patient Assistance Program - visit www.pap.novartis.com

About Trileptal

About Trileptal

Safety Profile

TRILEPTAL has been available in the United States since February 2000, and has been prescribed for over 1,000,000 patients. In addition, it has been in use in other countries since 1990.

Patients on other antiseizure medications may need to undergo regular blood test to check for liver enzyme abnormalities. With TRILEPTAL this type of routine monitoring is not necessary. If you are at risk of hyponatremia your doctor may want to monitor your sodium blood levels.



E-mail this page  | Print this page




TRILEPTAL Home  |  About Epilepsy & Seizures
Seizure Diagnoses & Treatment  |  Living with Epilepsy
Kids' Playground  |  Epilepsy Resources  |  About TRILEPTAL
Caregivers & Friends  |  "Dispense As Written" What it means for you
Important Safety Information  |  Full Prescribing Information
Healthcare Professionals

Site Guide  |  Contact Us  |  Site Map

Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement.
Copyright ©2008
Novartis Pharmaceuticals Corporation. All rights reserved.